1. Home
  2. NDAQ vs KVUE Comparison

NDAQ vs KVUE Comparison

Compare NDAQ & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDAQ
  • KVUE
  • Stock Information
  • Founded
  • NDAQ 1971
  • KVUE 2022
  • Country
  • NDAQ United States
  • KVUE United States
  • Employees
  • NDAQ N/A
  • KVUE N/A
  • Industry
  • NDAQ Investment Bankers/Brokers/Service
  • KVUE Specialty Chemicals
  • Sector
  • NDAQ Finance
  • KVUE Consumer Discretionary
  • Exchange
  • NDAQ Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • NDAQ 43.8B
  • KVUE 45.7B
  • IPO Year
  • NDAQ 2002
  • KVUE 2023
  • Fundamental
  • Price
  • NDAQ $78.76
  • KVUE $23.83
  • Analyst Decision
  • NDAQ Buy
  • KVUE Buy
  • Analyst Count
  • NDAQ 15
  • KVUE 12
  • Target Price
  • NDAQ $80.87
  • KVUE $22.64
  • AVG Volume (30 Days)
  • NDAQ 2.7M
  • KVUE 17.3M
  • Earning Date
  • NDAQ 10-24-2024
  • KVUE 11-07-2024
  • Dividend Yield
  • NDAQ 1.22%
  • KVUE 3.44%
  • EPS Growth
  • NDAQ N/A
  • KVUE N/A
  • EPS
  • NDAQ 1.68
  • KVUE 0.55
  • Revenue
  • NDAQ $7,017,000,000.00
  • KVUE $15,459,000,000.00
  • Revenue This Year
  • NDAQ N/A
  • KVUE $3.35
  • Revenue Next Year
  • NDAQ $7.50
  • KVUE $3.50
  • P/E Ratio
  • NDAQ $46.84
  • KVUE $43.10
  • Revenue Growth
  • NDAQ 16.97
  • KVUE N/A
  • 52 Week Low
  • NDAQ $53.36
  • KVUE $17.67
  • 52 Week High
  • NDAQ $80.77
  • KVUE $24.13
  • Technical
  • Relative Strength Index (RSI)
  • NDAQ 63.07
  • KVUE 61.37
  • Support Level
  • NDAQ $78.00
  • KVUE $23.04
  • Resistance Level
  • NDAQ $80.77
  • KVUE $23.95
  • Average True Range (ATR)
  • NDAQ 1.59
  • KVUE 0.63
  • MACD
  • NDAQ 0.20
  • KVUE 0.07
  • Stochastic Oscillator
  • NDAQ 71.04
  • KVUE 85.85

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: